Clinical Evaluation of Daily Disposable Contact Lenses

Completed · Not applicable

Conditions studied: Myopia

In brief

The objective of the study is to compare the overall subjective preference of filcon II 3 daily disposable silicone hyrogel contact lenses compared to etafilcon A and nelfilcon A daily disposable conventional hydrogel contact lenses.

Key facts

Study ID

NCT02097030

Run by

CooperVision, Inc.

People needed

35

Starts

2014-03-01

Expected to finish

2014-04-01

Last updated by the study team

2020-07-31

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Is between 18 and 40 years of age (inclusive)
• Has had a self-reported visual exam in the last two years
• Is an adapted soft CL wearer
• Must be able to wear their lenses at least 3 full days, 10 hours per day, assuming there are no contraindications for doing so
• Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)
• Has less than 1.25 D spectacle cylinder in each eye.
• Baseline vision of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.
• Is correctable to at least 20/25 distance visual acuity with study contact lenses in each eye
• Has clear corneas and no active ocular disease
• Has read, understood and signed the information consent letter
• Is willing to comply with the wear schedule (at least 3 full days)
• Is willing to comply with the visit schedule

You may not qualify if…

• Has never worn contact lenses before.
• Currently wears rigid gas permeable contact lenses.
• Has a history of not achieving comfortable CL wear (3 days per week; > 8 hours/day)
• Has a CL prescription outside the range of - 1.00 to -6.00D
• Has a spectacle cylinder greater than -1.25D of cylinder in either eye.
• Has best corrected spectacle distance vision worse then 20/25 in either eye.
• Has any systemic disease affecting ocular health.
• Is using any systemic or topical medications, (includes rewetting drops, artificial tears and allergy drops), that will affect ocular health. Occasional use is acceptable but not during the trial.
• Has any ocular pathology or severe insufficiency of lacrimal secretion
• Has persistent, clinically significant corneal or conjunctival staining
• Has active neovascularization or any central corneal scars.
• Is aphakic.
• Is presbyopic.
• Has undergone corneal refractive surgery.
• Is participating in any other type of eye related clinical or research study.

Where it is running

• University of California, Berkeley Clinical Research Center (UCB-CRC) — Berkeley, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.